Directorate Change

RNS Number : 9568R
JPMorgan Russian Securities PLC
01 November 2019
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN RUSSIAN SECURITIES PLC

 

NOTIFICATION OF BOARD CHANGES

 

Legal Entity Identifier:

549300II3MHI98ZLVH37

 

Information disclosed in accordance with Listing Rule 9.6.11(1) and (2)

 

The Board of JPMorgan Russian Securities plc (the Company) announces that in accordance with its Board Succession Plan, two directors of the Company have retired and two new non-executive directors have been appointed, as detailed below:

On 31st October 2019, Mr Alexander Easton and Mr George Nianias retired as non-executive directors of the Company. The Board thanked them for their contribution to the Company during their tenures since 2010 and 2008 respectively, and wished them all the best for the future.

On 1st November 2019, Mr Ashley Dunster and Mr Nicholas Pink were appointed as non-executive directors of the Company.

Mr Ashley Dunster has extensive investment management experience of funds investing in Russian companies and was Chief Investment Officer of Capital Group' s Private equity business until the end of 2018 when he retired after 21 years service. During that time his roles included involvement in six global emerging markets funds that invested approximately $6billion. 

 

Mr Nicholas Pink has extensive senior management experience in financial services with previous roles at UBS Investment Bank including Global Head of Research, Head of European Research, Head of Asia Research and Head of European Equities.

 

For both new directors, no further information is to be disclosed in respect of paragraphs 9.6.13 (2) - (6) of the UKLA Listing Rules.

 

1st November 2019

 

For further information, please contact:

 

Mr Paul Winship

JPMorgan Funds Limited - Company Secretary

Telephone 0207 742 4000

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUAAKRKWAARRA
Investor Meets Company
UK 100